Drug-Drug Interactions, Safety, and Pharmacokinetics of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non–Small Cell Lung Cancer

Inhibitors of the epidermal growth factor receptor (EGFR) are important treatment options for non–small cell lung cancer (NSCLC) patients with activating EGFR mutations. Erlotinib, gefitinib, afatinib, and osimertinib are approved for use in NSCLC patients, and several other agents are in clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucharczuk, Colleen R., Ganetsky, Alex, Vozniak, J. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302998/
https://www.ncbi.nlm.nih.gov/pubmed/30588353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302998/
https://www.ncbi.nlm.nih.gov/pubmed/30588353

Ejemplares similares